Advanced Therapeutics Pharmaceutical Outsourcing Market to Surge at a CAGR of 4.4% by 2034 Amid Growing Demand for Personalized Medicine

Future Market Insights, Inc. (FMI) reveals a surging advanced therapeutics pharmaceutical outsourcing market, propelled by cutting-edge treatments and the crucial role of specialized partners. Gene therapies, cell therapies, mRNA breakthroughs, and personalized medicine drive the need for expert support. Explore full report for insights & stakeholder opportunities.

NEWARK, Del., Jan. 16, 2024 /PRNewswire/ -- Future Market Insights (FMI)' latest industry analysis shows that the Global Advanced Therapeutics Pharmaceutical Outsourcing Market was valued at US$ 7,197.8 million in 2023. The market is projected to reach US$ 11,698.1 million, surging at a CAGR of 4.4% by 2034.

https://mma.prnewswire.com/media/1197648/3531122/FMI_Logo.jpg

Request Exclusive Sample Report: Advanced Therapeutics Pharmaceutical Outsourcing Industry Strategic Insights, https://www.futuremarketinsights.com/reports/sample/rep-gb-18755

Advanced therapeutics encompass a range of cutting-edge and innovative treatments, including gene therapies, cell therapies, mRNA-based therapies, and other personalized and precision medicine approaches. Pharmaceutical companies often collaborate with external partners, such as contract development and manufacturing organizations (CDMOs) and contract research organizations (CROs) service providers, to leverage their expertise, infrastructure, and capabilities in the complex and rapidly evolving field of advanced therapeutics.

The advanced therapeutics pharmaceutical outsourcing market is propelled by an array of drivers and opportunities that underscore its pivotal role in the dynamic landscape of advanced therapeutic development. Rapid advancements in gene therapy, cell therapy, and mRNA technologies are catalysts for outsourcing services, demanding specialized expertise to navigate their complexities.

The escalating pipeline of innovative therapies, especially those targeting rare diseases and oncology, provides a fertile ground for outsourcing partners to offer indispensable support in development and manufacturing. The globalization of clinical trials, driven by the trend toward personalized medicine, particularly in oncology, further amplifies the demand for outsourcing services with a global reach.

Technological innovations in manufacturing, such as continuous manufacturing and automation, present opportunities for outsourcing partners to enhance efficiency and scalability in producing advanced therapeutics. Strategic collaborations and partnerships between pharmaceutical companies, academic institutions, and outsourcing entities foster innovation and collectively address challenges in the rapidly evolving field.

As the market evolves, opportunities lie in expanding outsourcing services to cover a broader spectrum of advanced therapeutic modalities, meeting pharmaceutical clients' diverse and dynamic needs.

Scope of the Report



     
              Attribute                   
      
              Details



     Estimated Market Size (2024)           
      US$ 7,592.8 million



     Projected Market Size (2034)           
      US$ 11,698.1 million


      Anticipated Growth Rate (2024 to 2034)                                                                                                                                                          4.4 %



     Forecast Period                        
      2024 to 2034



     Historical Data Available for          
      2019 to 2023



     Market Analysis                        
      US$ million for Value


                                                                      United States                                                                  South Korea                                   Hungary
                                                                                
              Canada                                                          
              Germany                                             Romania
                                                                                                                                                                         
               
              France                                              
              India
                                                                                                     Mexico
                                                                          
              Brazil                                                                                               Spain                                                      Association of Southeast Asian
                                                                                       
               
              Chile                                       
              Italy                                    Nations Countries
                                                                                                                                                                  
               
              BENELUX                                      
              Australia and New
                                                                                                           China                                                                                                 Zealand
                                                                                 
              Japan                                                                                      Nordic Countries                             
              GCC Countries
                                                                                                                                                                 
              United                                                
          
              South
                                                                                                  Poland                                                                   Kingdom                                                      Africa

     Key Countries Covered                                                                                                                             
              BENELUX                                             Türkiye





     Key Market Segments Covered            
      
              Advanced Therapeutics Pharmaceutical Outsourcing Industry Segmentation

                                             
      By Service Type:

                                                Contract Research Organizations (CROs)
            Contract Development and Manufacturing Organizations (CDMOs)

                                             
      By Indication:

                                             
      Oncology
            Neurology
            Cardiology
            Infectious Diseases
            Others

                                             
      By Therapy:

                                             
      Cell Therapy
            Gene Therapy
            RNA-based Therapies
            Others

                                             
      By Phases:

                                             
      Preclinical Services
            Clinical Services
            Commercial Manufacturing and Packaging

                                             
      By Region:

                                                North America
            Latin America
            East Asia
            South Asia and Pacific
            Western Europe
                                                      Eastern Europe
            Middle East and Africa



     Key Companies Profiled

                                               Croda International Plc
            Charles River                                                Lonza Group
            Piramal            Recipharm AB
            Vetter
                                                 Laboratories International, Inc.                                                             Pharma Solutions
            SGS             Pharma International GmbH
                                                 Catalent, Inc.
            QuintilesIMS (IQVIA)                                                  SA
            Evotec SE                Cryoport Systems, Inc.
                                                     Parexel International Corporation                                                        CMC Biologics (Now AGC                   ProPharma Group
                                                     ICON plc
            PPD, Inc. (Thermo Fisher                                                Biologics)
            Marken (A                Fujifilm Diosynth
                                                 Scientific)
            LabCorp (Laboratory                                                      UPS Company)                     Biotechnologies
                                                 Corporation of America Holdings)
            Syneos                                              Cytovance Biologics              Medpace
            Novotech Pty
                                                 Health
            WuXi AppTec                                                                   Samsung Biologics                Ltd.
            Axcella Health
                                                                                                                                                CordenPharma                     Inc.
            CelerionAshland

Purchase this report now to get key companies with their Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis.

Key Takeaways from the Market Study

    --  By service type, contract development and manufacturing organizations
        (CDMOs) are expected to surge at a CAGR of surge at a CAGR of 3.7% by
        2034.
    --  By indication, oncology held a 46.1% market value share in 2023.
    --  By therapy, gene therapy held the leading share in the market of 49.6%
        in 2023.
    --  By phases, commercial manufacturing, and packaging segment dominates
        with the leading share, accounting for 54.9% in 2023.
    --  North America is the primary region, holding a substantial value share
        of 37.3% in 2023.

"Development and manufacturing of advanced therapeutics, such as gene and cell therapies, is responsible for the growth of the advanced therapeutics pharmaceutical outsourcing market worldwide," says Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.).

Competitive Landscape

The advanced therapeutics pharmaceutical outsourcing market encourages collaborative innovation, with pharmaceutical companies and outsourcing partners working together to advance technologies, overcome challenges, and bring novel therapies to market.

For instance,

    --  In June 2023, KD Pharma Group and DUDE CHEM announced their strategic
        partnership to usher in a new era of digital innovation, greatly
        enhancing the efficiency and safety of pharmaceutical drug and therapy
        development.
    --  In January 2021, Thermo Fisher Scientific, Inc. acquired the viral
        vector business from Henogen S.A (Groupe Novasep SAS).

Want more insights?

Future Market Insights brings a comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2019 to 2034. The global advanced therapeutics pharmaceutical outsourcing market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

The study provides compelling insights into the advanced therapeutics pharmaceutical outsourcing market segment based on service type - (contract research organizations (CROs), contract development and manufacturing organizations (CDMOs)), indication (oncology, neurology, cardiology, infectious diseases, others), therapy (cell therapy, gene therapy, RNA-based therapies, others) phases (preclinical services, clinical services, commercial manufacturing, and packaging) across seven major regions.

Request to Access the Detail Research Methodology from here!

About Healthcare Division at Future Market Insights (FMI)

Future Market Insights (FMI) facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you to devise innovation-driven trajectories for your business. Know more about our sector coverage here.

About the Author:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

Explore FMI's Extensive Coverage in the Healthcare Domain:

    --  Vitamin and Mineral Supplement Market by Vitamins and Minerals, from
        2024 to 2034. - Review and Request to Access the Sample PDF.
    --  Infection Prevention Market Forecast by Consumables and Disinfectors
        Products from 2024 to 2034. - Review and Request to Access the Sample
        PDF.
    --  Distance Health Technology Market Analysis by Telemedicine Hardware and
        Software from 2024 to 2034. - Review and Request to Access the Sample
        PDF.
    --  Topical Pain Relief Market Analysis by Creams, Gels, Patch, and Spray
        Formulations, 2024 to 2034. - Review and Request to Access the Sample
        PDF.
    --  Baby Safety Products Market by Product Type, Distribution Channel &
        Region | Forecast 2023 to 2033. - Review and Request to Access the
        Sample PDF.

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai and has delivery centers in the United Kingdom, the United States, and India. FMI's latest market research reports and industry analysis helps businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition.

Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us
Nandini Singh Sawlani
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn | Twitter | Blogs | YouTube

Logo: https://mma.prnewswire.com/media/1197648/3531122/FMI_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/advanced-therapeutics-pharmaceutical-outsourcing-market-to-surge-at-a-cagr-of-4-4-by-2034-amid-growing-demand-for-personalized-medicine-302035551.html

SOURCE Future Market Insights